AJ

Ashwin Jethalal Thacker

Active Director Director DIN 00048595
DIN 00048595 First appointment Jun 1986 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 4 historical roles
Total affiliations 9 Since Jun 1986
Shareholding value •••• Premium profile

About Ashwin Jethalal Thacker

Data last updated:

Ashwin Jethalal Thacker is a Director at Flamingo Pharmaceuticals Limited (since 1986), Designated Partner at Flamingo Healthcare Llp (since 2025) and Designated Partner at Mini Med Laboratories Llp (since 2024), and holds 2 more current directorships. The companies operate in Pharma. The largest current company by reported revenue is Flamingo Pharmaceuticals Limited at ₹637 Cr (FY 2026). Earlier, Ashwin Jethalal Thacker was a Director at Flamingo Healthcare Private Limited (from 2010) and Director at Mini Med Laboratories Pvt Ltd (from 1993) and 2 more.

DIN 00048595
Primary Designation Director
Industry Pharma
First Appointment 23 Jun 1986
Oldest Company Age 41 yrs
Largest company Flamingo Pharmaceuticals Limited · ₹637 Cr (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Flamingo Pharmaceuticals Limited U51900MH1985PLC036572
Director23 Jun 19861985₹637 Cr (FY 2026)Active
Designated Partner23 Mar 20252025Active
Designated Partner16 Jul 20242024Active
Designated Partner09 Jul 20242024Active
Designated Partner09 Jul 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Flamingo Healthcare Private Limited U24239MH2008PTC180639
Director25 Mar 20102008Converted To Llp
Mini Med Laboratories Pvt Ltd U33110MH1993PTC070699
Director08 Feb 19931993₹2,554 (FY 2024)Converted To Llp
Rotaline Molekule Private Limited U51397MH2006PTC163870
Director18 Aug 20062006Converted To Llp
Director22 Jul 20102010Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rotaline Molekule Llp
Flamingo Healthcare Private Limited
Mini Med Laboratories Pvt Ltd
Rotaline Molekule Private Limited
Premium access

Shareholding and investment profile for Ashwin Jethalal Thacker

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashwin Jethalal Thacker

Ashwin Jethalal Thacker currently holds 5 directorships: Flamingo Pharmaceuticals Limited (Director, since 23 Jun 1986, revenue ₹637 Cr (FY 2026)); Flamingo Healthcare Llp (Designated Partner, since 23 Mar 2025); Mini Med Laboratories Llp (Designated Partner, since 16 Jul 2024); Rotaline Molekule Llp (Designated Partner, since 09 Jul 2024); Flamingo Infra Developers Llp (Designated Partner, since 09 Jul 2024).

Ashwin Jethalal Thacker was first appointed on 23 Jun 1986 as Director at Flamingo Pharmaceuticals Limited. The most recent appointment on record is 23 Mar 2025 at Flamingo Healthcare Llp.

Ashwin Jethalal Thacker held 4 earlier board appointments: Flamingo Healthcare Private Limited (Director, from 25 Mar 2010); Mini Med Laboratories Pvt Ltd (Director, from 08 Feb 1993); Rotaline Molekule Private Limited (Director, from 18 Aug 2006); Flamingo Infra Developers Private Limited (Director, from 22 Jul 2010).

The current boards of Ashwin Jethalal Thacker's companies include Ashish Tayal (Flamingo Pharmaceuticals Limited), Chhotulal Rawa Bhagwat (Flamingo Pharmaceuticals Limited), Meena Sanjiv Kapadi (Flamingo Pharmaceuticals Limited), Parth Ashwin Thacker (Flamingo Pharmaceuticals Limited), Pranay Ashwin Thacker (Flamingo Pharmaceuticals Limited), Sukrut Jagdish Shah (Flamingo Pharmaceuticals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available